Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
80.04
-10.40 (-11.50%)
At close: Dec 19, 2025, 4:00 PM EST
81.64
+1.60 (2.00%)
After-hours: Dec 19, 2025, 5:01 PM EST
Disc Medicine Stock Forecast
Stock Price Forecast
The 13 analysts that cover Disc Medicine stock have a consensus rating of "Strong Buy" and an average price target of $108.85, which forecasts a 35.99% increase in the stock price over the next year. The lowest target is $75 and the highest is $153.
Price Target: $108.85 (+35.99%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Disc Medicine stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 8 | 7 | 7 | 7 | 6 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 12 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $91 → $109 | Buy | Maintains | $91 → $109 | +36.18% | Dec 16, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $86 → $114 | Strong Buy | Maintains | $86 → $114 | +42.43% | Nov 10, 2025 |
| Stifel | Stifel | Strong Buy Initiates $125 | Strong Buy | Initiates | $125 | +56.17% | Nov 3, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $90 → $115 | Buy | Maintains | $90 → $115 | +43.68% | Oct 30, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $89 → $108 | Strong Buy | Maintains | $89 → $108 | +34.93% | Oct 17, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
41.91M
EPS This Year
-6.21
from -3.96
EPS Next Year
-6.61
from -6.21
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 74.1M | ||||
| Avg | n/a | 41.9M | ||||
| Low | n/a | 11.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -6.20 | -5.61 | ||||
| Avg | -6.21 | -6.61 | ||||
| Low | -6.14 | -7.49 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.